Tender: Recommissioning National Cancer Audit Collaborating Centre to Deliver Ten Cancer Audits for NHS England and Wales

About

NHS England and the Welsh Government are seeking a supplier to recommission the National Cancer Audit Collaborating Centre (NATCAN) to deliver ten national cancer audits for NHS-funded care in England and Wales over an initial three-year contract with a core budget up to £11,145,600 including VAT (£9,288,000 excluding VAT); bids exceeding this core value will be rejected and pricing submissions must only reflect this core value. There is potential to extend the contract for up to two additional years at a potential value of £3,715,200 per year including VAT (£3,096,000 per year excluding VAT), and a potential ceiling value including aspirational intent and extensions of £28,029,455 including VAT (£23,357,879 excluding VAT), with possible discretionary inflationary uplifts. The Centre currently hosts audits for primary and metastatic breast cancer, bowel, kidney, lung, non-Hodgkin lymphoma, oesophago-gastric, ovarian, pancreatic and prostate cancer. Required activity includes delivery of the ten audits with a focus on treatment variation; comprehensive review and ongoing monitoring of reported metrics (clinical relevance, duplication avoidance, optimal data sources, publication frequency and reducing reporting lag); review and adjustment of data sources and scoping documents; planning for individual-level data linkages; ensuring robust methodological and statistical input; providing timely, accessible, benchmarked outputs across reporting levels; meaningful patient, carer and public involvement; collaborative working with NHS bodies, the National Disease Registration Service and Welsh Government; implementing technical solutions for unified visualisation of NATCAN outputs; and maximising consistency and harmonisation across the audit portfolio. Further details of the existing audit are available at natcan.org.uk.